Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium tuberculosis (Mtb) targets involved in membrane energetics in acidic environments represent a critical suite of proteins and complexes that allow the pathogen to survive within the hostile, acidic milieu of the host macrophage phagolysosome (pH 4.5–5.5) [1, 2]. This functional system primarily includes the F1F0-ATP synthase, the respiratory electron transport chain (ETC) components such as the cytochrome bc1-aa3 complex (QcrB) and cytochrome bd oxidase, and pH-regulatory proteins such as the acid-resistance protease MarP [3, 8]. These targets work coordinately to maintain the proton motive force (PMF), which is required for ATP synthesis and the active regulation of intrabacterial pH to prevent lethal cytoplasmic acidification [2, 11]. Drugs like Bedaquiline (targeting ATP synthase) and Telacebec (targeting QcrB) exploit the bacterium's increased reliance on these pathways under acid stress, leading to rapid ATP depletion and loss of viability [3, 12]. Additionally, the first-line drug Pyrazinamide is thought to act by disrupting membrane potential and energetics specifically in acidic environments [13]. Because these targets are vital for both actively replicating and non-replicating persistent Mtb populations, they are central to modern efforts to shorten tuberculosis treatment and combat multidrug-resistant strains [7, 10].
Inhibition of F1F0-ATP synthase, inhibition of cytochrome bc1-aa3 complex, disruption of proton motive force, and inhibition of acid-resistance proteases.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis targets involved in membrane energetics in acidic environments.